Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00926237 · ClinicalTrials.gov registry record · NA

Effect of rTMS on Resting State Brain Activity in Tinnitus

A NA study of Tinnitus, sponsored by University of Arkansas.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT00926237 is a NA study of Tinnitus that has completed, run by University of Arkansas. The registered enrollment target is 58 participants, below the 12,617-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00926237, a NA study of Tinnitus, has completed, sponsored by University of Arkansas.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

One out of every five people experiences tinnitus (a ringing, buzzing, or roaring sound in the ear) ranging from mild to severe impairment. To date, there are no effective therapies available that have been shown to decrease tinnitus awareness. The purpose of this study is to evaluate a treatment option for tinnitus that uses a technique called Repetitive Transcranial Magnetic Stimulation (rTMS), which could prove to be an effective means of alleviating or reducing the symptoms of tinnitus.

Conditions Studied

Tinnitus

Interventions

  • DEVICE Sham rTMS - Sham repetitive transcranial magnetic stimulation
  • DEVICE Active 1 Hz rTMS - Active repetitive transcranial magnetic stimulation delivered at 1 Hz frequency
  • DEVICE Active 10 Hz rTMS - active repetitive transcranial magnetic stimulation delivered at 10 Hz frequency

Study Locations (1)

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2009-01
Est. Completion 2019-09
Phase NA

Sponsor

University of Arkansas

318 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00926237

The ClinicalTrials.gov registry entry for NCT00926237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,617-participant average among 24 other Tinnitus trials with a reported enrollment target (100% lower). The listed sponsor is University of Arkansas, which has 318 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tinnitus appearing as the primary indexed condition, and to 3 interventions - of which Sham rTMS - Sham repetitive transcranial magnetic stimulation is the first listed.

NCT00926237 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT00926237 about?

NCT00926237 is a clinical study titled "Effect of rTMS on Resting State Brain Activity in Tinnitus". One out of every five people experiences tinnitus (a ringing, buzzing, or roaring sound in the ear) ranging from mild to severe impairment. To date, there are no effective therapies available that have been shown to decrease tinnitus awareness. The purpose of this study is to evaluate a treatment op...

What is the current status of trial NCT00926237?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2009-01. Estimated completion is 2019-09.

What conditions does trial NCT00926237 study?

This clinical trial studies the following conditions: Tinnitus.

What interventions are being tested in trial NCT00926237?

The interventions under investigation include: Sham rTMS - Sham repetitive transcranial magnetic stimulation (DEVICE), Active 1 Hz rTMS - Active repetitive transcranial magnetic stimulation delivered at 1 Hz frequency (DEVICE), Active 10 Hz rTMS - active repetitive transcranial magnetic stimulation delivered at 10 Hz frequency (DEVICE).

Who is sponsoring clinical trial NCT00926237?

This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00926237 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tinnitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tinnitus

All registered trials for this condition

Arkansas

All trials with a study site in Arkansas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.